Response to “Outdated Criteria for Drug Plan Reimbursement Obstruct Evidence-Based Care” Editorial in CMAJ CADTH Published July 19, 2022 PDF
Lenvatinib (Lenvima) in Combination With Pembrolizumab (Keytruda) CADTH Published July 12, 2022 PDF HTML
Normal Immunoglobulin (Human) 10% and Recombinant Human Hyaluronidase (HyQvia) CADTH Published July 4, 2022 PDF HTML
Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis CADTH Published July 19, 2022 PDF HTML
Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma Tara Cowling, Heather Neilson, Ransi Nayakarathna, Quenby Mahood Published July 28, 2022 PDF HTML
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder Deepa Jahagirdar, Quenby Mahood Published July 26, 2022 PDF HTML
Multiple Prosthetic Sockets for Lower Limb Amputations Calvin Young, Quenby Mahood Published July 19, 2022 PDF HTML
Diacetylmorphine for Adults With Opioid Dependence Khai Tran, Danielle MacDougall Published July 13, 2022 PDF HTML
Platform, Basket, and Umbrella Trial Designs: Issues Around Health Technology Assessment of Novel Therapeutics Jean-Eric Tarride, Matthew Cheung, Timothy P. Hanna, Lauren E. Cipriano, Dean A. Regier, Spencer Phillips Hey, Kelvin K.W. Chan, Nicole Mittmann Published July 6, 2022 PDF HTML
Platform, Basket, and Umbrella Trial Designs: Stakeholder Perspectives of Novel Therapeutics Nicole Mittmann, Kelvin K.W. Chan, Matthew Cheung, Valerie McDonald, Catherine Moltzan, Brent Fraser, Daria O’Reilly, Heather McDonald, Jason Lee, Jean-Eric Tarride Published July 6, 2022 PDF HTML
Intermittently Scanned and Real-Time Continuous Glucose Monitoring for People With Diabetes Keeley Farrell, Hannah Loshak Published July 4, 2022 PDF HTML
Trace Amine-Associated Receptor 1 Agonists for Schizophrenia Christopher Vannabouathong, Lory Picheca, Peter Dyrda Published July 14, 2022 PDF HTML
